Thesis (M.A.)--State University of New York at Binghamton, Department of Philosophy, 2009. / Includes bibliographical references (leaves 55-56).

Thesis (MNutr)--Stellenbosch University, 2013. / ENGLISH ABSTRACT: Objectives: The objectives of this study were to determine the nutritional content/ contribution of intravenous (IV) fluid and electrolyte administration on the total feeding prescription of intensive care unit (ICU) patients. Methods: Retrospective review of ICU charts of consecutive patients (>18 years) with APACHE II scores ≥10 and on ≥72 hours nutrition therapy (NT) admitted to a medical/surgical ICU. Total fluid, electrolyte, energy and macronutrient intake from nutritional and non-nutritional sources were reviewed from ICU admission until discharge, discontinuation of NT or death for ≤7 days. Energy and protein delivery were compared to calculated targets of 25.4 – 28.6kCal/kg and 1.3 – 1.5g/kg respectively. Summary statistics, correlation coefficients and appropriate analysis of variance were used to describe and analyse the data. Results: A total of 71 patients (49% male), average age 49.2 ± 17.1, average APACHE II score 21.0 ± 6.1, 68% medical and 32% surgical, were included. Fluid and nutrient intake were reviewed over a mean of 5.7 ± 1.1 days. Mean daily fluid delivery was 3.2 ± 0.6L. IV fluid therapy (IVFT) contributed 32.0 ± 12.0% to total fluid delivery (TFD), whereas IV drug administration, including fluids used for reconstitution and dilution purposes, contributed 20.7 ± 8.1% to TFD. Balanced electrolyte solutions (BES) were the crystalloid of choice, prescribed in 91.5% of patients with a mean daily volume (MDV) of 0.5 ± 0.4L. Hypertonic low molecular weight (LMW) 130/0.4kD hydroxyethyl starch (HES) was the colloid of choice, prescribed in 78.9% of patients with a MDV of 0.2 ± 0.1L. Potassium salts were the most frequently prescribed IV electrolyte supplement (IVES), prescribed in 91% of patients (±20 – 60mmol per administration). NT was initiated within 14.5 ± 14.1 hours. The majority (80%) received enteral nutrition (EN). The mean daily energy delivered was 1613 ± 380kCal (25.1kCal/kg), meeting 93.6 ± 17.7% of mean target range (MTR). Mean daily protein delivery (PD) was 72 ± 22g (1.1g/kg), meeting 82.8 ± 19.9% of MTR. Non-nutritional energy sources (NNES), mostly derived from carbohydrate-containing IV fluids, contributed 10.1 ± 7.5% to total energy delivered (156kCal/d). Mean cumulative energy and protein balance was -674.0 ± 1866.1kCal and -86.0 ± 106.9g respectively. The majority (73%) received >90% of the minimum energy target but only 49% >90% of minimum protein target; 59% of those with energy intake 90-110% of target had adequate protein intake. A significant negative correlation was found between cumulative energy/protein balance and the time to initiation of NT (energy: r=-0.28, p=0.02; protein: r=-0.32, p=0.01). Conclusion: In this ICU BES are the crystalloid of choice and hypertonic LMW 130/0.4kD HES the colloid of choice for IVFT. Potassium salts are the most frequently prescribed IVES. NNES added significantly to energy delivery and should be included in the calculation of feeding prescriptions to avoid the harmful effects of overfeeding. Early initiation of EN with conventional products which are energy rich is insufficient to achieve adequate PD. EN formulae with a more favorable nitrogen to non-protein energy ratio could help to optimise PD during the first week of ICU care. / AFRIKAANSE OPSOMMING: Doelwitte: Die doelwit van hierdie studie was om die voedingswaarde/ bydrae van intraveneuse (IV) vog en elektroliet toediening tot die totale voedings voorskrif van pasiënte in ‘n intensiewe sorg eenheid (ISE) te bepaal. Metodes: Retrospektiewe bestudering van die ISE kaarte van agtereenvolgende pasiënte (>18 jaar) opgeneem in ‘n mediese/chirurgie ISE en met APACHE II tellings ≥10 en ≥72 ure voedingsterapie (VT). Totale vog, elektroliet, energie en makronutriënt inname vanaf voedingsverwante en nie-voedingsverwante bronne is vanaf ISE opname tot en met ontslag, staking van VT of sterfte, vir ≤7 dae hersien. Energie en proteiën inname is vergelyk met berekende doelwitte van 25.4 – 28.6kKal/kg en 1.3 – 1.5g/kg onderskeidelik. Beskrywende statisitiek, korrelasie koeffisiënte en toepaslike analises van variansie is gebruik vir data analise. Resultate: 71 pasiënte (49% mans), gemiddelde ouderdom 49.2 ± 17.1, gemiddelde APACHE II telling 21.0 ± 6.1, 68% medies en 32% chirurgie, is ingesluit. Vog en voedingstof inname is hersien oor ‘n gemiddelde tydperk van 5.7 ± 1.1 dae. Gemiddelde vog inname was 3.2 ± 0.6L/dag. IV vog terapie (IVVT) het 32.0 ± 12.0% bygedra tot totale vog inname (TVI). IV medikasie toediening, insluitende die herkonstruksie en verwatering van medikasie, het 20.7 ± 8.1% bygedra tot TVI. Die mees voorgeskrewe kristalloiëd en kolloiëd vir IVVT was gebalanseerde elektroliet oplossings (GEO), voorgeskryf in 91.5% van pasiënte (gemiddeld 0.5 ± 0.4L/dag), en hipertoniese lae molekulêre gewig (LMG) 130/0.4kD hidroksie-etiel stysel (HES), voorgeskryf in 78.9% van pasiënte (gemiddeld 0.2 ± 0.1L/dag), onderskeidelik. Die mees voorgeskrewe IV elektroliet supplement was kalium soute, voorgeskryf in 91% van pasiënte (±20 – 60 mmol per toediening). VT is binne 14.5 ± 14.1 ure geinisieër. Die meerderheid (80%) het enterale voeding (EV) ontvang. Die gemiddelde daaglikse energie inname van 1613 ± 380kCal (25.1kKal/kg) het 93.6 ± 17.7% van die gemiddelde doelwit rykwydte (GDR) bereik. Die gemiddelde daaglikse proteiën inname van 72 ± 22g (1.1g/kg) het 82.8 ± 19.9% van die GDR bereik. Nie voedings-verwante energie bronne (NVEB), meestal vanaf koolhidraat-bevattende IV vloeistowwe, het 10.1 ± 7.5% tot totale energie inname (TEI) bygedra (156kKal/d). Die gemiddelde kumulatiewe energie en proteiën balans was -674.0 ± 1866.1kKal en -86.0 ± 106.9g onderskeidelik. Die meerderheid (73%) het >90% van die minimum energie doelwit (ED) bereik. Slegs 49% het >90% van die minimum proteiën doelwit (PD) bereik. Opsomming: Die kristalloiëd en kolloiëd van keuse vir IVT is GEO en hipertoniese LMG 130/0.4kD HES onderskeidelik. Kalium soute word mees algemeen voorgeskryf. NVEB dra beduidend by tot TEI en moet inaggeneem word tydens die berekening van voedingsvoorskrifte ten einde oorvoeding te voorkom. Vroeë inisiëring van EV met konvensionele energie-ryke EV produkte is onvoldoende om genoegsame proteiën inname te verseker. EV produkte met ‘n gunstiger stikstof tot nie-proteiën energie verhouding sal help om proteiën inname gedurende die eerste week van intensiewe sorg te optimaliseer.Slegs 59% van pasiënte met genoegsame energie inname (90-110% van ED) het hul minimum PD bereik. Daar was ‘n beduidende negatiewe korrelasie tussen kumulatiewe energie/proteiën balans en die tyd tot inisiëring van VT (energie: r=-0.28, p=0.02; proteiën: r=-0.32, p= 0.01).

Nutrientes específicos, denominados farmaconutrientes, demonstraram possuir a capacidade de modular a resposta imunológica e inflamatória de animais e seres humanos, em estudos clínicos e laboratoriais. Dentre os substratos conhecidos, os que têm maior relevância e ação imunomoduladora são a arginina, glutamina, ácido graxo n-3 e nucleotídeos. No entanto, revisões sistemáticas e meta-análises buscam consenso em relação aos vários e controversos resultados publicados sobre os possíveis benefícios da imunonutrição em pacientes críticos. Nossos objetivos foram avaliar a efetividade das dietas enriquecidas com Imunonutrientes na redução de complicações e mortalidade nos diferentes tipos de pacientes críticos. O presente estudo é uma revisão sistemática com metanálise onde foram inseridos ensaios clínicos randomizados avaliando o uso de nutrientes imunomoduladores em doente adulto de ambos os sexos, definido como crítico traumatizado, séptico, queimado ou cirúrgico; as dietas utilizadas deveriam conter um ou mais dos imunonutrientes, em qualquer dose, administradas por via enteral comparadas à dieta padrão pela mesma via em pelo menos um dos grupos de comparação. As bases de dados consultadas foram Pubmed e Cinhal, utilizando os termos: Immunonutrition, arginine, glutamine, n-3, nucleotides e criticall illness. De 206 artigos encontrados inicialmente, apenas 35 preencheram os critérios de elegibilidade estabelecidos. Destes 35 ensaios clínicos, 18 foram conduzidos em pacientes cirúrgicos, 6 em pacientes traumatizados, 5 em pacientes queimados, 5 em pacientes críticos em geral e 1 em pacientes sépticos. Para a população geral, não houve redução significativa do risco de morrer indicada pelo RR de 0,84 (IC de 0,68 a 1,05) e os queimados foram mais protegidos de morrer com RR de 0,25 (IC de 0,09 a 0,66); as complicações infecciosas foram reduzidas com RR de 0,56 (IC de 0,42 a 0,73); a incidência de sepse foi reduzida com RR de 0,45 (IC de 0,29 a 0,69), especialmente nos pacientes traumatizados com RR de 0,42 (IC de 0,26 a 0,68); a incidência de abscesso abdominal também foi reduzida com RR de 0,39 (IC de 0,21 a 0,72) e também de bacteremia com RR de 0,46 (IC de 0,31 a 0,66); o tempo de internação hospitalar diminuiu -3,9 dias (IC de -5,0 a -2,8). Para a população de pacientes cirúrgicos: o óbito não apresentou redução significativa do RR de 0,93 (IC de 0,44 a 1,95), as complicações infecciosas foram reduzidas com RR de 0,51 (IC de 0,41 a 0,63), o tempo de internação hospitalar foi reduzido - 3,41 dias (IC de -4,25 a -2,58) e o tempo de internação em UTI -1,72 dias (IC de -2,12 a -1,31). A utilização de dietas com nutrientes imunomoduladores não alterou a mortalidade em doentes críticos ou cirúrgicos. Indivíduos com mais de 60 anos são menos protegidos de morrer pela utilização de dietas com imunomoduladores. As complicações infecciosas são reduzidas em pacientes críticos com a utilização de imunonutrição, em especial a população de pacientes cirúrgicos. Dietas com mais de 10g/l de arginina protegem mais os pacientes críticos da incidência de complicações infecciosas. Pacientes traumatizados são protegidos da incidência de sepse pela utilização da imunonutrição. O tempo de internação hospitalar e o tempo de internação em UTI foram reduzidos em críticos e cirúrgicos com imunonutrição. A execução de ensaios clínicos explanatórios nos diferentes tipos de doentes críticos com um nutriente imunomodulador isolado, seguida de ensaios pragmáticos de acordo com os resultados dos anteriores, é um fato a ser considerado em futuras pesquisas. / Specific nutrients, the so-called pharmaconutrients, showed a capability to modulate human and animal immune answers in clinical and laboratory studies. Amongst the well-known substracts, arginine, glutamine, fatty accid n-3, and nucleotide showed the most relevant immunomodulator actions. However, systematic revisions and meta-analysis are still in search of agreement due to several controversial results published in the literature on the probable benefits of the immunonutrition of the critically ill. Evaluate the effectiveness of the immunonutrients enriched diets in the reduction of complications and mortality of different types of the critically ill patients. The present study is a meta-analysis systematic revision where randomized clinical trials were included, evaluating the immunomodulator nutrients use in ill adults of both genders, defined as critical traumatized, septicemic, burned, or surgical patients; diets administered should contain one or more immunonutrients, at any dose, ministered by enteral route and compared with a pattern diet offered by the same via at least to one of the comparison groups. Pubmed and Cinhal data banks were searched for the following terms: immunonutrition, arginine, glutamine, n-3, nucleotides and critical illness. In 206 articles were initially found, but only 35 agreed to the established electability criteria: 18 were conducted in the surgical patients, 6 in the traumatized patients, 5 in the burned patients, 5 in the general critical patients, and 1 in the septicemic patients. Considering the general population: obit did not show a significant RR reduction of 0.84 (IC from 0.68 to 1.05); burned patients were more protected from death with RR of 0.25 (IC from 0.09 to 0.66); infections complications were reduced with RR of 0.56 (IC from 0.42 to 0.73); sepsis incidence was reduced with RR of 0.45 (IC from 0.29 to 0.69); specially in the traumatized patients with RR of 0.42 (IC from 0.26 to 0.68); abdominal abscess incidence was also reduced with RR of 0.39 (IC from 0.21 to 0.72) and also bacteremia with RR of 0.46 (IC from 0.31 to 0.66); hospitalization time was also reduced in -3.9 days (IC from -5.0 to -2.8). Considering the surgical patients population: obit did not present a significant RR reduction of 0.93 (IC from 0.44 to 1.95); infections complications were reduced with RR of 0.51 (IC from 0.41 to 0.63); hospitalization period was reduced in -3.41 days (IC from -4.25 to -2.58), and in the ICU time was reduced in -1.72 days (IC from -2.12 to -1.31). Administration of immunomodulator nutrient diets did not change the mortality of the critically ill or surgical patients. Individuals over 60 years are less protected from death with the administration of immunomodulator diets. Infections complications showed a reduction in the critically ill patients with the utilization of immunonutrition, specially the surgical patients population. Diets containing more than 10g/l of arginine protect the critical patients from the incidence of infectious complications. Traumatized patients are protected from the incidence of sepsis by the administration of the immunonutrition. Hospitalization and ICU time were reduced for critical and surgical patients in use of immunonutrition. Explanatory clinical trials in different types of critically ill patients using an isolated immunomodulator nutrient followed by pragmatic trials according to previous results should be considered in future research.

Nutrientes específicos, denominados farmaconutrientes, demonstraram possuir a capacidade de modular a resposta imunológica e inflamatória de animais e seres humanos, em estudos clínicos e laboratoriais. Dentre os substratos conhecidos, os que têm maior relevância e ação imunomoduladora são a arginina, glutamina, ácido graxo n-3 e nucleotídeos. No entanto, revisões sistemáticas e meta-análises buscam consenso em relação aos vários e controversos resultados publicados sobre os possíveis benefícios da imunonutrição em pacientes críticos. Nossos objetivos foram avaliar a efetividade das dietas enriquecidas com Imunonutrientes na redução de complicações e mortalidade nos diferentes tipos de pacientes críticos. O presente estudo é uma revisão sistemática com metanálise onde foram inseridos ensaios clínicos randomizados avaliando o uso de nutrientes imunomoduladores em doente adulto de ambos os sexos, definido como crítico traumatizado, séptico, queimado ou cirúrgico; as dietas utilizadas deveriam conter um ou mais dos imunonutrientes, em qualquer dose, administradas por via enteral comparadas à dieta padrão pela mesma via em pelo menos um dos grupos de comparação. As bases de dados consultadas foram Pubmed e Cinhal, utilizando os termos: Immunonutrition, arginine, glutamine, n-3, nucleotides e criticall illness. De 206 artigos encontrados inicialmente, apenas 35 preencheram os critérios de elegibilidade estabelecidos. Destes 35 ensaios clínicos, 18 foram conduzidos em pacientes cirúrgicos, 6 em pacientes traumatizados, 5 em pacientes queimados, 5 em pacientes críticos em geral e 1 em pacientes sépticos. Para a população geral, não houve redução significativa do risco de morrer indicada pelo RR de 0,84 (IC de 0,68 a 1,05) e os queimados foram mais protegidos de morrer com RR de 0,25 (IC de 0,09 a 0,66); as complicações infecciosas foram reduzidas com RR de 0,56 (IC de 0,42 a 0,73); a incidência de sepse foi reduzida com RR de 0,45 (IC de 0,29 a 0,69), especialmente nos pacientes traumatizados com RR de 0,42 (IC de 0,26 a 0,68); a incidência de abscesso abdominal também foi reduzida com RR de 0,39 (IC de 0,21 a 0,72) e também de bacteremia com RR de 0,46 (IC de 0,31 a 0,66); o tempo de internação hospitalar diminuiu -3,9 dias (IC de -5,0 a -2,8). Para a população de pacientes cirúrgicos: o óbito não apresentou redução significativa do RR de 0,93 (IC de 0,44 a 1,95), as complicações infecciosas foram reduzidas com RR de 0,51 (IC de 0,41 a 0,63), o tempo de internação hospitalar foi reduzido - 3,41 dias (IC de -4,25 a -2,58) e o tempo de internação em UTI -1,72 dias (IC de -2,12 a -1,31). A utilização de dietas com nutrientes imunomoduladores não alterou a mortalidade em doentes críticos ou cirúrgicos. Indivíduos com mais de 60 anos são menos protegidos de morrer pela utilização de dietas com imunomoduladores. As complicações infecciosas são reduzidas em pacientes críticos com a utilização de imunonutrição, em especial a população de pacientes cirúrgicos. Dietas com mais de 10g/l de arginina protegem mais os pacientes críticos da incidência de complicações infecciosas. Pacientes traumatizados são protegidos da incidência de sepse pela utilização da imunonutrição. O tempo de internação hospitalar e o tempo de internação em UTI foram reduzidos em críticos e cirúrgicos com imunonutrição. A execução de ensaios clínicos explanatórios nos diferentes tipos de doentes críticos com um nutriente imunomodulador isolado, seguida de ensaios pragmáticos de acordo com os resultados dos anteriores, é um fato a ser considerado em futuras pesquisas. / Specific nutrients, the so-called pharmaconutrients, showed a capability to modulate human and animal immune answers in clinical and laboratory studies. Amongst the well-known substracts, arginine, glutamine, fatty accid n-3, and nucleotide showed the most relevant immunomodulator actions. However, systematic revisions and meta-analysis are still in search of agreement due to several controversial results published in the literature on the probable benefits of the immunonutrition of the critically ill. Evaluate the effectiveness of the immunonutrients enriched diets in the reduction of complications and mortality of different types of the critically ill patients. The present study is a meta-analysis systematic revision where randomized clinical trials were included, evaluating the immunomodulator nutrients use in ill adults of both genders, defined as critical traumatized, septicemic, burned, or surgical patients; diets administered should contain one or more immunonutrients, at any dose, ministered by enteral route and compared with a pattern diet offered by the same via at least to one of the comparison groups. Pubmed and Cinhal data banks were searched for the following terms: immunonutrition, arginine, glutamine, n-3, nucleotides and critical illness. In 206 articles were initially found, but only 35 agreed to the established electability criteria: 18 were conducted in the surgical patients, 6 in the traumatized patients, 5 in the burned patients, 5 in the general critical patients, and 1 in the septicemic patients. Considering the general population: obit did not show a significant RR reduction of 0.84 (IC from 0.68 to 1.05); burned patients were more protected from death with RR of 0.25 (IC from 0.09 to 0.66); infections complications were reduced with RR of 0.56 (IC from 0.42 to 0.73); sepsis incidence was reduced with RR of 0.45 (IC from 0.29 to 0.69); specially in the traumatized patients with RR of 0.42 (IC from 0.26 to 0.68); abdominal abscess incidence was also reduced with RR of 0.39 (IC from 0.21 to 0.72) and also bacteremia with RR of 0.46 (IC from 0.31 to 0.66); hospitalization time was also reduced in -3.9 days (IC from -5.0 to -2.8). Considering the surgical patients population: obit did not present a significant RR reduction of 0.93 (IC from 0.44 to 1.95); infections complications were reduced with RR of 0.51 (IC from 0.41 to 0.63); hospitalization period was reduced in -3.41 days (IC from -4.25 to -2.58), and in the ICU time was reduced in -1.72 days (IC from -2.12 to -1.31). Administration of immunomodulator nutrient diets did not change the mortality of the critically ill or surgical patients. Individuals over 60 years are less protected from death with the administration of immunomodulator diets. Infections complications showed a reduction in the critically ill patients with the utilization of immunonutrition, specially the surgical patients population. Diets containing more than 10g/l of arginine protect the critical patients from the incidence of infectious complications. Traumatized patients are protected from the incidence of sepsis by the administration of the immunonutrition. Hospitalization and ICU time were reduced for critical and surgical patients in use of immunonutrition. Explanatory clinical trials in different types of critically ill patients using an isolated immunomodulator nutrient followed by pragmatic trials according to previous results should be considered in future research.

Introdução: Há poucos estudos avaliando qualidade de vida relacionada à saúde (QVRS) e anos de vida ajustados para qualidade de vida (QALY) em pacientes com câncer que necessitam internação em unidades de terapia intensiva. O objetivo deste estudo foi avaliar sobrevida, QVRS e QALY durante o seguimento a longo prazo de pacientes com câncer internados em UTI. Métodos: Realizamos uma coorte prospectiva de pacientes com câncer admitidos em duas UTIs do estado de São Paulo. Coletamos dados na admissão da UTI, incluindo QVRS antes da doença aguda que motivou internação em UTI e no seguimento em 15 dias, 3 meses, 6 meses, 12 meses e 18 meses para avaliar a QVRS e status vital. Adicionalmente, o status vital foi avaliado em 24 meses. QVRS foi determinada com o questionário EQ-5D-3L. A sobrevida foi calculada com o estimador de Kaplan-Meier e o QALY com uma adaptação do estimador Zhao e Tsiatis. Resultados: Foram incluídos 792 pacientes. A média de idade foi 61,6±14,3 anos, 42,5% dos pacientes eram do sexo feminino e metade foi admitida após cirurgia eletiva. A média do escore SAPS3 foi 47,4±15.6. A probabilidade de sobreviver 12 e 18 meses foi 42.4% e 38.1%, respectivamente. A média do índice de utilidade da QVRS antes da internação na UTI foi 0,47±0,43, aos 15 dias pós-admissão a UTI 0,41±0,44, aos 3 meses 0,56±0,42, aos 6 meses 0,60±0,41, aos 12 meses 0,67±0,35 e aos 18 meses 0,67±0,35. A probabilidade de atingir 12 e 18 meses de vida ajustados para qualidade de vida foi de 30.1% e 19.1%, respectivamente. Houve diferenças estatisticamente significativas do tempo de sobrevida e QALY conforme as características de base consideradas (admissão após cirurgia eletiva, cirurgia de urgência ou clínica; SAPS3; extensão do câncer; status do câncer; cirurgia prévia; quimioterapia prévia; radioterapia prévia; capacidade funcional; e QVRS prévia). No entanto, apenas QVRS prévia e capacidade funcional foram associados a QVRS ao longo do seguimento de 18 meses. Conclusão: Em pacientes com câncer admitidos em UTI, a sobrevida, QVRS e QALY a longo prazo são limitados. Entretanto, há bastante variabilidade entre os pacientes nestes desfechos clínicos que é associada a características simples presentes na admissão à UTI e que podem auxiliar a equipe de saúde a avaliar o prognóstico / Introduction: Only few studies assessed health-related quality of life (HRQOL) and quality-adjusted life years (QALY) of cancer patients admitted to intensive care units (ICU). We aimed to assess the long-term HRQOL and QALY of cancer patients admitted to ICUs. Methods: We conducted a prospective cohort study of cancer patients admitted to two ICUs from the state of São Paulo, Brazil. We assessed the HRQOL with the EQ-5D-3L before ICU admission, 15 days, 3, 6, 12 and 18 months. In addition, the vital status was assessed at 24 months. Survival was calculated with the Kaplan-Meier estimator and QALY with the adapted Zhao and Tsiatis estimator. Results: The mean age of the subjects was 61.6 ± 14.3 years, 42.5% were female and half were admitted after elective surgery. The mean Simplified Acute Physiology Score (SAPS) 3 was 47.4 ± 15.6. Survival at 12 and 18 months was 42.4% and 38.1%, respectively. The mean EQ5D utility measure before admission to the ICU was 0.47±0.43, at 15 days it was 0.41±0.44, at 90 days 0.56±0.42, at 6 months 0.60±0.41, at 12 months 0.67±0.35 and at 18 months 0.67±0.35. The probabilities for attaining 12 and 18 months of quality-adjusted survival were 30.1% and 19.1%, respectively. There were statistically significant differences in survival time and QALYs according to all assessed baseline characteristics (ICU admission after elective surgery, emergency surgery or medical admission; SAPS3; cancer extension; cancer status; previous surgery; previous chemotherapy; previous radiotherapy; performance status; and previous HRQOL). Only the previous HRQOL and performance status were associated with the HRQOL during the 18-month follow-up. Conclusion: Long-term HRQOL, survival and QALY expectancy of cancer patients admitted to the ICU are limited. Nevertheless, these clinical outcomes exhibit wide variability among patients and are associated with simple characteristics present at the time of ICU admission, which may help healthcare professionals estimate patients\' prognose

Submitted by Aline Batista (alinehb.ufpel@gmail.com) on 2018-05-16T13:55:58Z No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertacao_Cíntia_Valente_Gonçalves.pdf: 944490 bytes, checksum: cc70fe882bcf06d57d873236f6a036ae (MD5) / Approved for entry into archive by Aline Batista (alinehb.ufpel@gmail.com) on 2018-05-16T20:21:38Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertacao_Cíntia_Valente_Gonçalves.pdf: 944490 bytes, checksum: cc70fe882bcf06d57d873236f6a036ae (MD5) / Approved for entry into archive by Aline Batista (alinehb.ufpel@gmail.com) on 2018-05-16T20:21:55Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertacao_Cíntia_Valente_Gonçalves.pdf: 944490 bytes, checksum: cc70fe882bcf06d57d873236f6a036ae (MD5) / Made available in DSpace on 2018-05-16T20:21:55Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertacao_Cíntia_Valente_Gonçalves.pdf: 944490 bytes, checksum: cc70fe882bcf06d57d873236f6a036ae (MD5) Previous issue date: 2015-03-12 / Sem bolsa / A desnutrição do paciente em tratamento intensivo tem sido evidenciada em inúmeros estudos e o suporte nutricional inadequado é fator determinante para o surgimento de complicações, podendo contribuir para a maior mortalidade. O presente estudo consistiu em determinar a adequação da terapia nutricional enteral em pacientes críticos internados na Unidade de Terapia intensiva do Hospital Universitário Dr. Miguel Riet Correa Júnior da Universidade Federal do Rio Grande – FURG, identificar os fatores limitantes na administração da dieta e avaliar a adequação energética e proteica perante a evolução clínica do paciente até o fim da internação na unidade. Foram incluídos todos os pacientes de ambos os sexos que receberam terapia nutricional enteral por um período superior a 72 horas entre maio e novembro de 2014. O estado nutricional foi avaliado através da Avaliação Subjetiva Global na admissão do paciente na UTI e reaplicada semanalmente. O cálculo das necessidades energéticas e proteicas foi realizado de acordo com as recomendações para paciente crítico. Os dados foram coletados diariamente através dos registros dos prontuários do paciente. A adequação energética e proteica foi determinada através da razão entre os valores administrados e prescritos, sendo considerados adequados valores iguais ou maiores a 70% do prescrito. Essa adequação foi relacionada com o tempo de internação, tempo de ventilação mecânica e mortalidade. Foram avaliados 32 pacientes, com idade média de 56,4 ± 17,4 anos, sendo 59,4% do gênero masculino. Somente 21 (65,6%) atingiram percentuais superiores ou iguais a 70% de calorias prescritas, enquanto que para a oferta proteica 19 (59,4%) pacientes atingiram valores iguais ou superiores a 70%. A média de adequação calórica foi de 72,3% e a média de adequação proteica foi de 70,2%. A média de adequação volume de dieta infundido foi de 72,6% perante o prescrito. Foram identificadas 213 interrupções da nutrição enteral, 81,3% dos pacientes tiveram a dieta suspensa em razão de pausas para procedimentos e exames, 56,3% apresentaram piora clínica, 53,1% apresentaram intolerâncias do trato gastrointestinal, 50,0% tiveram erros na administração da dieta e 31,3% apresentaram problemas com a sonda. Não houve relação entre a adequação energética e proteica igual ou superior a 70,0% em pacientes recebendo TNE exclusiva em relação ao tempo de internação, tempo de ventilação mecânica e mortalidade. Mais estudos são necessários para determinar o valor seguro de adequação calórica e proteica, visando à melhora da saúde do paciente em UTI e minimizando intercorrências relacionadas à TNE. / Malnutrition in intensive care has been demonstrated in studies and inadequate nutrition is a determining factor for the complications and may contribute to the higher mortality. This study aimed to evaluate the adequacy of enteral nutrition therapy in critically ill patients admitted to the Intensive Care Unit of the Hospital Dr. Miguel Riet Correa Junior of the Federal University of Rio Grande - FURG and its association to the clinical evolution. Was included all patients who received enteral nutrition therapy for more than 72 hours between May and November 2014. Nutritional status was assessed by the Subjective Global Assessment on admission to the ICU and reapplied weekly. The energy and protein requirements were calculated using the recommendations for critical patients. Data were collected to patient's records. Energy and protein adequacy was determined by the ratio between administered and prescribed. Up to 70% of the prescribed was considered adequate. The adequacy was associated to the length of stay, duration of mechanical ventilation and mortality. 32 patients were included (mean age was 56.4 ± 17.4 years, 59.4% were man). Only 21 (65.6%) patients achieved up to 70% of calories requirement and 19 (59.4%) patients achieved up to 70% of protein requirement. The means of adequacy were 72.3% for calories, 70.2% for protein and 72.6% for diet volume. 213 interruptions of enteral nutrition were identified, 81.3% of patients had suspended diet due to break for procedures and tests, 56.3% had clinical worsening, 53.1% showed gastrointestinal symptoms, 50.0% had wrong administration in the enteral nutrition and 31.3% had problems with the enteral tube. There was no association between energy and protein intake with the length of stay, duration of mechanical ventilation and mortality in critically ill patients. More studies are needed to determine the value of caloric and protein adequacy, aimed at improving patient health in ICU and minimizing complications related to enteral nutrition.

Les effets des catécholamines en réanimation sont peu prédictibles. La variabilité interindividuelle des observations est d’origine multifactorielle dont des facteurs pharmacocinétiques et pharmacodynamiques, dépendant de caractéristiques constitutionnelles et acquises de chaque individu. Les posologies de l’adrénaline et de la noradrénaline chez l’enfant sont extrapolées des données adultes. Pourtant l’âge est une source de grande variabilité liée au développement. Un modèle pharmaco- statistique de l’adrénaline et de la noradrénaline a été établi chez l’enfant en insuffisance circulatoire aigüe. Il a permis d’identifier des facteurs de variabilité entre les individus ainsi que de proposer des schémas de prescription des deux molécules en fonction de l’effet souhaité et des caractéristiques de l’enfant. La pharmacocinétique de l’adrénaline chez 39 enfants en prévention du syndrome de bas débit cardiaque postopératoire suivait un modèle monocompartimental. La clairance augmentait avec le poids selon le principe de l’allométrie. Les augmentations résultantes de la fréquence cardiaque et de la pression artérielle moyenne suivaient un modèle d’effet direct Emax. Elles étaient influencées par l’âge et la gravité des patients. Les augmentations de glycémie et lactatémie suivaient un modèle d’effet indirect. Pour la noradrénaline, chez 38 enfants atteints d’hypotension artérielle systémique, la pharmacocinétique était mono-compartimentale. La clairance était influencée par le poids (allométrie). L’augmentation induite de la pression artérielle moyenne suivait un modèle direct Emax. Elle était fonction de l’âge et de la gravité des patients. Les posologies de l’adrénaline et de la noradrénaline chez l’enfant devraient tenir compte du poids, de l’âge et de la gravité du patient : plus jeune est l’enfant et plus grave est son état, plus la posologie doit être élevée pour satisfaire les objectifs hémodynamiques. / The effects of catecholamines are difficult to predict. The between-subject variability observed in clinical setting is multifactorial including constitutional and acquired characteristics of each individual. Epinephrine and norepinephrine dosages are usually extrapolated from adult data. Yet, age is a source of high variability due to development- related phenomena. A population model of epinephrine or norepinephrine was developed in haemodynamically critically ill children. This allowed to identify between-subject variability factors as well as to propose individualized dosage regimens of these two catecholamines according to the desired effect and child characteristics. Epinephrine pharmacokinetics in 39 children at high risk of postoperative low cardiac output syndrome followed a one-compartment model. Clearance increased with bodyweight according to the allometric rule. The resulting increases in heart rate and mean arterial pressure followed a direct Emax model. These were related to age and illness severity. A turn-over model described the increases in blood glucose and lactate. Norepinephrine pharmacokinetics in 38 hypotensive critically ill children followed a one compartment model. Clearance increased with bodyweight (allometry). The resulting increase in mean arterial pressure followed a direct Emax model. This was a function of age and illness severity. The dosage of epinephrine and norepinephrine in children should take into account the bodyweight, age and illness severity of the patient: the younger the child and the more serious the condition, the higher the dosage in order to meet the haemodynamic goals.

La malnutrition à l’admission en réanimation pédiatrique est fréquente et associée à une augmentation de la morbi-mortalité. Néanmoins, la plupart des études, limitées à une évaluation statique du statut nutritionnel, ne permettent pas une analyse fine de l’impact de la malnutrition. Une approche systémique associerait en plus d’une évaluation nutritionnelle statique, une analyse dynamique dans le temps, une analyse de la composition corporelle et une analyse physiopathologique et étiologique. Cette approche globale a été appliquée dans 4 études prospectives observationnelles, incluant des enfants sévèrement agressés de plus de 36 semaines d’âge corrigé. Il en ressort que la dénutrition globale à l’admission est fréquente (23,7%) et que la cassure des courbes de croissance avant l’admission est associée à une augmentation de la durée de séjour de 3 jours. L’enfant sévèrement agressé présente à l’admission des taux plasmatiques abaissés de 6 micronutriments impliqués dans le stress oxydant (Sélénium, Zinc, Cuivre, Vitamines C, E et bêta-carotène), proportionnellement au nombre de défaillances d’organe. La dénutrition globale et la fonte musculaire acquises en cours de séjour sont des phénomènes fréquents, précoces et importants, associés à une durée de séjour prolongée. Les changements métaboliques liés à l’agression sévère conduisent à une dénutrition. Ces processus adaptatifs sont parfois dépassés et la dénutrition pourra à son tour aggraver le pronostic. La bonne compréhension de la physiopathologie sous-jacente et un suivi systémique et systématique du statut nutritionnel sont les éléments indispensables à l’évaluation des stratégies nutritionnelles / Malnutrition at pediatric Intensive care unit (PICU) admission is frequent and associated with impaired outcomes. However, most studies have focused solely on a static definition. A holistic approach would improve the description of malnutrition: this would include both a static and dynamic assessment of nutritional status, together with body composition assessment and with malnutrition classified based on its patho-physiology and etiology. This holistic assessment of malnutrition has been applied and examined in four observational studies which included critically ill children older than 36 gestational weeks (corrected age). These found that malnutrition was frequent at PICU admission (27.3%) and faltering growth prior to PICU admission was associated with an increased length of PICU stay (+3 days). Critically ill children present at admission with decreased plasma levels of 6 micro-nutrients (Selenium, Copper, Zinc, Vitamin C, E and beta-carotene) involved in anti-oxidative stress pathways. Nutritional status deterioration during PICU stay, and associated muscle mass loss occurred frequently and were intense. This early phenomenon was associated with extended length of PICU stay. A profound critical illness related metabolic shift leads to malnutrition as an adaptive process. However, malnutrition may also negatively impact on outcomes in this setting. These studies have led to a clearer understanding of the underlying patho-physiology. This, combined with a more systematic and holistic nutritional assessment, will enable implementation and assessment of nutritional strategies aiming to improve the functional outcome of critically ill children

Introduction: The high transmissibility and lethality of the novel coronavirus SARS-CoV-2 (COVID-19) have been catastrophic. Acute kidney injury (AKI) is one of the frequent complications in patients with respiratory insufficiency caused by the virus. The pathogenic mechanism is based on the binding of its S-proteins to the angiotensin-converting enzyme (ACE) receptors, which will trigger a cellular damage. A podocyte and tubular compromise are found in the kidneys which can lead to tubular necrosis and the consequent AKI. Objectives: The objective of this report is to identify the main risk factor to develop AKI in patients infected with SARS-CoV-2 with critical acute respiratory distress. Patients and Methods: We performed this report study, collecting data from 48 ICU patients. Data from 13 of them who developed AKI and needed renal replacement therapy (RRT)were analyzed. Clinical characteristics and laboratory findings were reported using STATA 10.0. Results: AKI was present in 27.08% of patients, mostly male (92.3%) with a mean age of 63.8 years old. Hypertension, diabetes and obesity were the main comorbidities in those patients. Additionally, the meantime between admission and AKI diagnosis was 2.69 days. All patients showed fibrinogen, D-dimer, ALT and values above normal range. Mortality was seen in 61.5% of patients. Conclusion: This report tries to show AKI as an important clinical manifestation in critically ill patients infected with SARS-CoV-2, with high mortality. Further studies are needed to demonstrate if there are independent risk factors. / Revisión por pares

Glycaemic control in critically ill patients has been a topic of considerable attention for the past 20 years. In literature and at scientific meetings, there have been ongoing debates regarding the efficacy of glycaemic control in these patients with frequently entirely opposite opinions. These range from a strict invasive approach with target glycaemia 4-6 mmol/l to a liberal approach tolerating even values higher than 12 mmol/l. In the preview of this PhD thesis we have analysed so far published literature and describe the reasons for this inconsistency. According to the results of recent studies, the most significant efficacy of tight glycaemic control has been observed in cardiac surgical patients. If we consider the concept of tight glycaemic control as efficient strategy, there are three important questions remaining unanswered as follow. Does the specific algorithm-protocol play a key part in the concept of tight glycaemic control alongside the knowledge and skills of nursing staff in safe and efficient blood glucose control? What is the ideal timing of starting the strategy of tight glycaemic control (TGC) in cardiac surgical patient? And is there any benefit in outcome respect to mortality or morbidity? Do we have any more safe and efficient option or add-on to standard perioperative...